Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Masimo Corp (NASDAQ:MASI)

92.96
Delayed Data
As of 3:59pm ET
 -0.31 / -0.33%
Today’s Change
39.24
Today|||52-Week Range
96.68
+37.92%
Year-to-Date
MedTech Long-Term Prospects Impress: Which Stocks to Buy?
Mar 22 / Zacks.com - Paid Partner Content
3 Medical Device Stocks to Brave Policy Uncertainty
Mar 16 / Zacks.com - Paid Partner Content
Masimo (MASI) Up 20.6% Since Earnings Report: Can It Continue?
Mar 17 / Zacks.com - Paid Partner Content
Can The Uptrend Continue for Masimo (MASI)?
Mar 10 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close93.27
Today’s open93.32
Day’s range92.12 - 93.85
Volume627,307
Average volume (3 months)674,108
Market cap$4.7B
Dividend yield--
Data as of 3:59pm ET, 03/23/2017

Growth & Valuation

Earnings growth (last year)+264.52%
Earnings growth (this year)-58.88%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+11.46%
P/E ratio16.5
Price/Sales5.16
Price/Book8.36

Competitors

 Today’s
change
Today’s
% change
ABMDAbiomed Inc+0.28+0.23%
NUVANuVasive Inc-0.25-0.34%
WSTWest Pharmaceutical ...-0.23-0.29%
IARTIntegra LifeSciences...-0.55-1.28%
Data as of 4:01pm ET, 03/23/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)$0.58
Annual revenue (last year)$694.6M
Annual profit (last year)$300.7M
Net profit margin43.28%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Joe E. Kiani
Chief Operating Officer
Anand Sampath
Corporate headquarters
Irvine, California

Forecasts


Search for Jobs